Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Evaluation of Nano Hydroxyapatite Reinforced Glass Ionomer in Treatment of Root Caries in Geriatric Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04701320
Recruitment Status : Active, not recruiting
First Posted : January 8, 2021
Last Update Posted : January 8, 2021
Sponsor:
Information provided by (Responsible Party):
Reham nabil mahmoud, Cairo University

Brief Summary:
In geriatric patients, will the clinical performance of nano hydroxyapatite reinforced glass ionomer be better than conventional glass ionomer cement in treatment of root caries lesions over one year follow up?

Condition or disease Intervention/treatment Phase
Dental Restoration Failure Drug: Conventional glass ionomer Drug: Nano hydroxyapatite reinforced glass ionomer Phase 1

Detailed Description:
Glass carbomers are commercialized under the name of GCP Glass Fill, this material may be an interesting subject of research, certainly its bioactive properties as the manufacturer claims this material to have remineralizing properties. If this is the case, GCP Glass Fill could be an interesting reference material for further bioactivity studies

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Clinical Evaluation of Nano Hydroxyapatite Reinforced Glass Ionomer Versus Conventional Glass Ionomer in Treatment of Root Caries in Geriatric Patients: A Randomized Controlled Clinical Trial
Actual Study Start Date : July 7, 2019
Actual Primary Completion Date : July 7, 2019
Estimated Study Completion Date : August 9, 2021

Resource links provided by the National Library of Medicine

Drug Information available for: Durapatite

Arm Intervention/treatment
Experimental: Glass carbomer
Nano hydroxyapatite Reinforced Glass Ionomer that results in chemical bond formation with tooth structure mimic that of enamel tissue
Drug: Nano hydroxyapatite reinforced glass ionomer
Nanohydroxyapatite reinforced glass ionomer restorative material with enhanced mechanical proberties and chemical adhesion to tooth structure
Other Name: Glass carbomer

Active Comparator: Fuji ix
Conventional Glass Ionomer cement fluoride-releasing restorative system that combines fluoride release of glass ionomer cement and acceptable esthetics, a wear resistant, self-adhesive
Drug: Conventional glass ionomer
Conventional glass ionomer with enhanced mechanical and esthetic proberties
Other Name: Fujiix gc corporation




Primary Outcome Measures :
  1. Clinical restorative performance Service (USHPS) [ Time Frame: Change from the baseline at 3, 6 and12 months ]
    Change in the clinical behavior of the restoration (e.g. anatomical contour, shade match, secondary caries) using modified United State Public Health clinical evaluation assessment method Service (USHPS)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • • ≥ 50 years old

    • Males or females.
    • Community-dwelling
    • Have five or more of their own teeth
    • With ≥ 1 root caries lesion

Exclusion Criteria:

  • • Patients younger than 50 years old

    • Disabilities.
    • Systemic diseases or severe medically compromised.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04701320


Locations
Layout table for location information
Egypt
Faculty of dentistry
Cairo, Egypt, 002
Sponsors and Collaborators
Cairo University
Layout table for additonal information
Responsible Party: Reham nabil mahmoud, associate lecturer, Cairo University
ClinicalTrials.gov Identifier: NCT04701320    
Other Study ID Numbers: OPER 3-3-6
First Posted: January 8, 2021    Key Record Dates
Last Update Posted: January 8, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Supporting Materials: Study Protocol
Time Frame: one year

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Reham nabil mahmoud, Cairo University:
Glass Carbomer GCP glass fill root caries Clinical perfomance
Additional relevant MeSH terms:
Layout table for MeSH terms
Root Caries
Dental Caries
Tooth Demineralization
Tooth Diseases
Stomatognathic Diseases
Methamphetamine
Central Nervous System Stimulants
Physiological Effects of Drugs
Sympathomimetics
Autonomic Agents
Peripheral Nervous System Agents
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Adrenergic Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Dopamine Uptake Inhibitors